The Decrease in Healthcare‐Associated Methicillin‐Resistant Staphylococcus aureus Infections and Savings From Glycopeptide Use
From the Department of Microbiology, Medical Faculty, Istanbul Science University (D.C.), and the Department of Infectious Diseases and Clinical Microbiology, Florence Nightingale Hospital (J.A.), Caglayan, Istanbul, Turkey
We evaluated changes in the rate of healthcare‐associated methicillin‐resistant Staphylococcus aureus (MRSA) infections and healthcare‐associated S. aureus infections after implementation of infection control precautions and the effect of this on glycopeptide use and expenditures for glycopeptides in a private medical center in Turkey in the years 2000‐2005. A striking decrease was obtained in the number of MRSA infections, and the expenditure for glycopeptide use also decreased.
Received March 21, 2006; accepted May 19, 2006; electronically published September 20, 2006.
Cited by
Online publication date: 1-Sep-2008.
CrossRef



